Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:TQR's EV-to-FCF is ranked better than 90.27% of 565
companies
in the Drug Manufacturers industry
Industry Median: 20.96
vs FRA:TQR: 4.83
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Tong Ren Tang Chinese Medicine Co's PE Ratio (TTM) for today is calculated as:
Beijing Tong Ren Tang Chinese Medicine Co's share price for today is €0.73.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beijing Tong Ren Tang Chinese Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.052.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Beijing Tong Ren Tang Chinese Medicine Co EV-to-FCF Related Terms
Beijing Tong Ren Tang Chinese Medicine Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tong Ren Tang Chinese Medicine Co EV-to-FCF Chart
Beijing Tong Ren Tang Chinese Medicine Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tong Ren Tang Chinese Medicine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tong Ren Tang Chinese Medicine Co EV-to-FCF vs Drug Manufacturers Industry
Beijing Tong Ren Tang Chinese Medicine Co's current Enterprise Value is €426.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beijing Tong Ren Tang Chinese Medicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €86.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) has a EV-to-FCF of 4.90 as of Jul. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. This is 69% below median its historical median of 15.99. According to the industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #55 out of 565 companies in the Drug Manufacturers industry, placing it in the top 9.7%.
Is Beijing Tong Ren Tang Chinese Medicine Co's EV-to-FCF too high?
Beijing Tong Ren Tang Chinese Medicine Co's current EV-to-FCF of 4.90 is 69% below median its 10-year median of 15.99. The Drug Manufacturers industry median EV-to-FCF is 20.96. Beijing Tong Ren Tang Chinese Medicine Co's value of 4.90 is 76.6% below this industry median. Based on the distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #55 out of 565 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #55 out of 565 companies for EV-to-FCF. This places Beijing Tong Ren Tang Chinese Medicine Co in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 20.96. Beijing Tong Ren Tang Chinese Medicine Co's value of 4.90 is 76.6% below this benchmark. While the company's 10-year median is 15.99 vs. the industry median of 20.96, Beijing Tong Ren Tang Chinese Medicine Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tong Ren Tang Chinese Medicine Co's current EV-to-FCF of 4.90 is 76.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Tong Ren Tang Chinese Medicine Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tong Ren Tang Chinese Medicine Co's current EV-to-FCF is 4.90, which is 69% below median its own 10-year median of 15.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) is currently considered Significantly Undervalued. The stock's GF Value™ is €1.05, compared to a current price of €0.73 — trading 30.5% below its estimated fair value. The current EV-to-FCF is 4.90, which is 69% below median its 10-year median of 15.99 and 76.6% below the Drug Manufacturers industry median of 20.96. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR), the current EV-to-FCF is 4.90 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued.
The current stock price of €0.73 is trading 30.5% below its estimated GF Value™ of €1.05.
GuruFocus considers Beijing Tong Ren Tang Chinese Medicine Co to be Significantly Undervalued.
Key valuation signals for FRA:TQR:
EV-to-FCF: 4.90 (69% below median its 10-year median of 15.99)
GF Value™: €1.05 vs. price of €0.73 (30.5% below fair value)
Industry Position: 76.6% below the Drug Manufacturers median (#55 of 565)
No single metric tells the full story. See the FRA:TQR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tong Ren Tang Chinese Medicine Co Business Description
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
72GF Score
Get the complete analysis for FRA:TQR
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TQR has been successfully added to your 
